Literature DB >> 8856088

Developmental change of megakaryocyte maturation and DNA ploidy in human fetus.

D C Ma1, Y H Sun, K Z Chang, W Zuo.   

Abstract

Megakaryocytes in fetal livers obtained from 30 water-balloon aborted normal fetuses of 3 to 6 months' gestation, in the bone marrow from the same 30 fetuses, and another 9 fetuses of 7 to 8 months' gestation and in the normal bone marrow of adults were analyzed by immunocytochemical staining for size and maturation stage distribution and by flow cytometry for ploidy distribution simultaneously. In human fetuses, megakaryocytes showed a shift during ontogenesis from smaller towards larger size and from less mature towards a more mature stage with advancement of gestation. This was accompanied by a significant progressive shift to higher ploidy. However, the proportions (78.64%) of hypoploidy (< or = 8N) megakaryocytes in bone marrow of 7-8 months' gestation fetuses was still much higher than that (33.32%) in human adults (p < 0.05), with the proportion of hyperploidy (> or = 16N) megakaryocytes lower than that (67.86%) in human adults. This result indicated that megakaryocyte polyploidization may be retarded or inhibited during development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856088     DOI: 10.1111/j.1600-0609.1996.tb01349.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  11 in total

1.  Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish.

Authors:  Megan S Rost; Ilya Shestopalov; Yang Liu; Andy H Vo; Catherine E Richter; Sylvia M Emly; Francesca G Barrett; David L Stachura; Michael Holinstat; Leonard I Zon; Jordan A Shavit
Journal:  Blood Adv       Date:  2018-12-11

2.  Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes.

Authors:  Karen M Pastos; William B Slayton; Lisa M Rimsza; Linda Young; Martha C Sola-Visner
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

Review 3.  Megakaryocyte ontogeny: Clinical and molecular significance.

Authors:  Kamaleldin E Elagib; Ashton T Brock; Adam N Goldfarb
Journal:  Exp Hematol       Date:  2018-03-02       Impact factor: 3.084

Review 4.  Development of autologous blood cell therapies.

Authors:  Ah Ram Kim; Vijay G Sankaran
Journal:  Exp Hematol       Date:  2016-06-21       Impact factor: 3.084

Review 5.  Changes in megakaryopoiesis over ontogeny and their implications in health and disease.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Platelets       Date:  2020-03-21       Impact factor: 3.862

Review 6.  The Fetal-to-Adult Hematopoietic Stem Cell Transition and its Role in Childhood Hematopoietic Malignancies.

Authors:  Ryan Mack; Lei Zhang; Peter Breslin Sj; Jiwang Zhang
Journal:  Stem Cell Rev Rep       Date:  2021-08-23       Impact factor: 6.692

7.  Fetal vs adult megakaryopoiesis.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

8.  Observational Study on Variation of Longitudinal Platelet Counts in Calves over the First 14 Days of Life and Reference Intervals from Cross-Sectional Platelet and Leukocyte Counts in Dairy Calves up to Two Months of Age.

Authors:  Emma Strous; Arne Vanhoudt; Anja Smolenaars; Gerdien van Schaik; Matthijs Schouten; Henrik de Pater; Bjorn Roelofs; Mirjam Nielen
Journal:  Animals (Basel)       Date:  2021-01-29       Impact factor: 2.752

Review 9.  Developmental changes in hematopoietic stem cell properties.

Authors:  Michael R Copley; Connie J Eaves
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

10.  Phosphorylation of ribosomal protein S6 kinase 1 at Thr421/Ser424 and dephosphorylation at Thr389 regulates SP600125-induced polyploidization of megakaryocytic cell lines.

Authors:  Chang-Ling Li; Jin-Gang Yang; Di Lin; Yong-Shan Zhao; Shuo Liu; Si-Ning Xing; Song Zhao; Cong-Qin Chen; Zhi-Ming Jiang; Fei-Fei Pu; Jian-Ping Cao; Dong-Chu Ma
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.